A workshop was held at the 6th Accelerating Biopharmaceutical Development meeting in
Carlsbad, CA on February 18, 2019. An anonymous survey was sent to all industry …

Flexible manufacturing systems are needed in the pharmaceutical industry due to the future
challenges of volatility, uncertainty, complexity, and ambiguity [1]. Compared to traditional …

Long before the COVID-19 pandemic put a spotlight on supply-chain security and drug
shortages, the pharmaceutical industry was working on advanced manufacturing …

The traditional paradigm for pharmaceutical manufacturing is focused primarily upon
centralized facilities that enable mass production and distribution. While this system reliably …

In a recent survey of current trends and practices in biopharmaceutical manufacturing,
BioPharrn International readers revealed a preference for disposable systems, identified …

Developing new pharmaceutical products has become increasingly challenging due to
rising costs, increased complexity in the types of drugs, and changing patient demands. To …

The biopharmaceutical industry is dynamic and complex, and in addition to the overall
consistent 14-15% industry growth, data from BioPlan Associates' 2017 14th Annual Report …

The white papers presented here are a remarkable collection of work, unified by the goal of
building upon the in-roads that continuous manufacturing has made in the pharmaceutical …

The biopharmaceutical industry must begin designing and building a new generation of
highly capable, multi-purpose manufacturing facilities to meet the commercial manufacturing …

The pharmaceutical industry has the reputation of being cautious about implementing new
technology and slow to make changes. This conservatism is due, at least in part, to …